FRNRX
Price
$42.82
Change
+$0.30 (+0.71%)
Updated
Jul 13 closing price
Net Assets
487.82M
GHAYX
Price
$54.09
Change
+$0.20 (+0.37%)
Updated
Jul 13 closing price
Net Assets
565.41M
Interact to see
Advertisement

FRNRX vs GHAYX

FRNRX vs GHAYX Comparison Chart in %
View a ticker or compare two or three
VS
FRNRX vs. GHAYX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRNRX is a Buy and GHAYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GHAYX has more cash in the bank: 565M vs. FRNRX (488M). GHAYX pays higher dividends than FRNRX: GHAYX (1.64) vs FRNRX (1.47). FRNRX was incepted earlier than GHAYX: FRNRX (31 years) vs GHAYX (16 years). GHAYX (1.18) is less costly to investors than FRNRX (1.01). GHAYX is a more actively managed with annual turnover of: 58.00 vs. FRNRX (19.72). FRNRX (1000) and GHAYX (1000) have matching initial minimum investment requirements. FRNRX annual gain was more profitable for investors over the last year : 36.70 vs. GHAYX (26.71). FRNRX return over 5 years is better than : 121.43 vs. GHAYX (56.02).
FRNRXGHAYXFRNRX / GHAYX
Total Expense Ratio1.001.1388%
Annual Report Gross Expense Ratio1.011.1886%
Fund Existence31 years16 years-
Gain YTD16.3978.018205%
Front Load6%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets488M565M86%
Annual Yield % from dividends1.471.6490%
Returns for 1 year36.7026.71137%
Returns for 3 years56.9040.90139%
Returns for 5 years121.4356.02217%
Returns for 10 years82.9777.82107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGI0.55N/A
-0.04%
Birks Group
LAZ41.10-0.31
-0.75%
Lazard
EME764.90-16.88
-2.16%
EMCOR Group
CRBP9.04-0.64
-6.61%
Corbus Pharmaceuticals Holdings
DSGN13.85-1.33
-8.79%
Design Therapeutics